Association of elevated circulating iron with bone mineral density and bone turnover markers in postmenopausal Saudi women with and without osteoporosis
Objectives: To explore the associations of serum iron indices with bone mineral density (BMD) and bone turnover markers (BTMs) in postmenopausal Saudi women with and without osteoporosis.
Methods: This cross-sectional study included 184 postmenopausal women aged ≥45 years (75 osteoporotic and 109 controls). Anthropometric and biochemical parameters were assessed. Serum iron, transferrin, total iron-binding capacity (TIBC), and transferrin saturation (TSAT) were measured. Bone-specific alkaline phosphatase (BsALP), osteocalcin, and osteopontin were evaluated. Participants were classified based on serum iron levels (50-170 μg/dL [normal circulating iron] and >170 μg/dL [elevated circulating iron]). BMD was measured at the lumbar spine and femur by dual-energy X-ray absorptiometry (DXA).
Results: Osteoporotic women had significantly lower BMD at the spine and femur (p<0.001). Elevated circulating iron was observed in 54.3 % of participants. Serum iron weakly correlated with osteocalcin (r=0.17, p=0.02) and osteopontin (r=0.17, p=0.049) only in unadjusted analyses. All observed associations were not supported by the primary adjusted analysis.
Conclusions: The primary adjusted analysis showed no statistically significant association between elevated circulating iron and osteoporosis risk. The observed weak associations between serum iron and selected bone turnover markers should be considered exploratory. Findings do not support an independent association between elevated circulating iron and postmenopausal osteoporosis.
Objectives: To explore the associations of serum iron indices with bone mineral density (BMD) and bone turnover markers (BTMs) in postmenopausal Saudi women with and without…
Background/Objectives: Magnesium (Mg) is an essential micronutrient that participates in more than 300 enzymatic reactions, with well-established functions in glucose and lipid…
Emerging imaging and computational technologies are reshaping how osteoporosis and low bone mass are assessed.